Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
becaplermin (regranex) (3 trials)
calcium (1 trial)
calcium phosphate (1 trial)
parathyroid hormone (Natpara) (1 trial)
rasburicase (Elitek) (1 trial)
vitamin d3 (1 trial)
Diabetic Foot (Phase 3)
Foot Ulcer (Phase 3)
Hyperuricemia (Phase 3)
Osteoporosis (Phase 3)
Ulcer (Phase 3)
Trials (5 total)
Trial APIs (6 total)